DD
37
3
AAPL
56
3
BEN
22
-4
HBAN
67
2
EFX
66
5
SYK
44
5
O
44
5
MTCH
40
18
SNA
50
4
RHI
27
3
BF.B
48
-3
MKC
66
3
AMAT
36
5
PYPL
33
15
HAS
48
-7
SPG
48
2
F
54
4
SLG
48
2
MHK
42
2
MTB
55
5
DD
37
3
AAPL
56
3
BEN
22
-4
HBAN
67
2
EFX
66
5
SYK
44
5
O
44
5
MTCH
40
18
SNA
50
4
RHI
27
3
BF.B
48
-3
MKC
66
3
AMAT
36
5
PYPL
33
15
HAS
48
-7
SPG
48
2
F
54
4
SLG
48
2
MHK
42
2
MTB
55
5
Financhill
Back

Leap Therapeutics Stock Price Chart

AI Marketing Shift Is Happening–Act Before It's Too Late!

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
11

LPTX
Leap Therapeutics

Last Price:
$0.30
Seasonality Move:
-4.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LPTX is experiencing slight buying pressure.

Leap Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.38 Sell
20-day SMA: 0.4 Sell
50-day SMA: 0.68 Sell
200-day SMA: 2.18 Sell
8-day EMA: 0.37 Sell
20-day EMA: 0.43 Sell
50-day EMA: 0.85 Sell
200-day EMA: 2 Sell

Leap Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 25.53 Sell
Chaikin Money Flow: -42798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.37 - 0.45) Sell
Bollinger Bands (100): (0.59 - 3.13) Sell

Leap Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Leap Therapeutics Stock

Is Leap Therapeutics Stock a Buy?

  • Leap Therapeutics share price is 0.31 while LPTX 8-day simple moving average is 0.38, which is a Sell signal.
  • The stock price of LPTX is 0.31 while Leap Therapeutics 20-day SMA is 0.40, which makes it a Sell.
  • Leap Therapeutics 50-day simple moving average is 0.68 while LPTX share price is 0.31, making it a Sell technically.
  • LPTX stock price is 0.31 and Leap Therapeutics 200-day simple moving average is 2.18, creating a Sell signal.

LPTX Technical Analysis vs Fundamental Analysis

Sell
11
Leap Therapeutics (LPTX) is a Sell

Is Leap Therapeutics a Buy or a Sell?

  • Leap Therapeutics stock is rated a Sell
    The current Leap Therapeutics [LPTX] share price is $0.31. The Score for LPTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.

Leap Therapeutics Stock Info

Market Cap:
12.6M
Price in USD:
0.31
Share Volume:
902.2K

Leap Therapeutics 52-Week Range

52-Week High:
4.79
52-Week Low:
0.28
Sell
11
Leap Therapeutics (LPTX) is a Sell

Leap Therapeutics Share Price Forecast

Is Leap Therapeutics Stock a Buy?

  • Leap Therapeutics share price is 0.31 while LPTX 8-day exponential moving average is 0.37, which is a Sell signal.
  • The stock price of LPTX is 0.31 while Leap Therapeutics 20-day EMA is 0.43, which makes it a Sell.
  • Leap Therapeutics 50-day exponential moving average is 0.85 while LPTX share price is 0.31, making it a Sell technically.
  • LPTX stock price is 0.31 and Leap Therapeutics 200-day simple moving average is 2.00, creating a Sell signal.

Fundamental Analysis of Leap Therapeutics

Is Leap Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.39 per share.

Technical Analysis of Leap Therapeutics

Should I short Leap Therapeutics stock?

* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.